期刊文献+

氨酚待因2号片的药代动力学及其相对生物利用度的研究 被引量:3

THE PHARMACOKINETICS OF No 2 ACETAMINOPHEN-CODEINE COMPOUND TABLET IN NORMAL VOLUNTEERS
原文传递
导出
摘要 氨酚待因2号片是一改进的解热镇痛复方药,其中含扑热息痛300 mg/片,磷酸可待因15 mg/片。作为新的复方药,有必要对其药代动力学进行研究。本文用原料药配成水剂与片剂对比,计算相对生物利用度。用HPLC和GC-MS法分别检测了8位正常健康志愿者一次po氨酚待因2号片剂或水剂(30 mg磷酸可待因和600mg扑热息痛)后血浆中可待因和扑热息痛的含量。结果如下:po两片氨酚待因2号片后,扑热息痛的药代动力学符合二室模型;t_(peak)=0.74 h±s 0.43 h,C_(max)=8.04 mg·L^(-1)±s 3.96 mg·L^(-1),t_(1/2)=2.81 h±s1.09 h,Clr=0.39 L·h^(-1)±s 0.12 L·h^(-1),Cls=30.77 L·h^(-1)±s 9.02 L·h^(-1)。氨酚待因片中的可待因的药代动力学符合二室模型;t_(peak)=0.87 h±s 0.15 h,C_(max)=50.65μg·L^(-1)±s10.17μg·L^(-1),t_(1/2)=3.11h±s 0.49h,Clr=16.12L·h^(-1)±s 2.02L·h^(-1),Cls=173L·h^(-1)±s 11.40 L·h^(-1);po水剂对照药后,扑热息痛和可待因的药代动力学房室模型均与po片剂的药代规律相似,统计学上无显著差异(P>0.05)。扑热息痛和可待因的相对生物度分别为99.97%±s 10.55%,100.73%±s 7.85%。 A comparative pharmacokinetics between tablet and solution of acetaminophen - codeine compound (cotaining 300 mg acetaminophen and 15 mg codeine in each tablet ) was carried out in 8 male volunteers. Each man was given two tablets or the solution of combination of the same dosage of codeine and acetaminophen after an over night fasting. The samples of the plasma and urine were collected, and detected by HPLC for acetaminophen and GC - MS for codeine. The results were as follows: 1. the drug level-time of acetaminophen and codeine are fitted to two open - compartment model. The parameters of acetaminophen were: tpeak=0.74 h±s 0.43h, Cmax = 8.04 mg · L-1 ± s 3. 96 mg · L-1, t1/2β = 2.81 h±s 1.09 h, Clr = 0.39 L · h-1±s 0.12 L · h-1, Cls =30.77 L · h-1±s 9.02 h · L-1. The parameters of codeine were: tpeak=0.87 h ± s 0.15 h, Gmax= 0. 65 μug · L-1 ± s 10.17 μg · L-1, t1/2β= 3. 11 h ±s 0.49 h, Clr = 16. 12 L · h-1±s 2. 02 L · h-1, Cls = 173 L · h-1 ± s 11.40 L · h-1; 2. the drug level-time of acetaminophen and codeine of solution are also fitted to two open - compartment model. Their pharmacokinetic parameters was all similiar to those of drugs in tablet. The relative bioavailability of acetaminophen and codeine was 99.97% ±s 10.55% and 100.73% ±s 7.85% respectively.
出处 《中国药物依赖性通报》 CSCD 1994年第4期227-232,共6页
  • 相关文献

参考文献2

同被引文献12

  • 1刘丽京,邓艳萍,魏伟,沈黎阳,楼雅卿.反相高效液相色谱法测定血浆中酒石酸双氢可待因/对乙酰氨基酚浓度的方法[J].中国临床药理学杂志,2004,20(3):212-214. 被引量:9
  • 2邓艳萍,王凯,刘静雯,许光炘,蔡志基.血浆中可待因的GC-MS检测法及其在药代研究中的应用[J].中国药物依赖性通报,1993,2(3):203-205. 被引量:1
  • 3宋晓坤,谢广茹,陈立正,郑宝森,贾英杰,姚菁,马淑萍.6种复方可待因制剂临床疗效评价[J].中国医院药学杂志,2005,25(10):958-960. 被引量:3
  • 4[3]Zhao RC, Felix B, Andrew S. Simultaneous determination of codeine, norcodeine and morphine in biological fluids by high performance liquid chromatography with fluorescence detection[J]. J Chromatogr, 1989;491:367-378.
  • 5王文玲,许光炘,刘静雯,等.正常人口服氨酚待因片的扑热息痛药代动力学研究[J].中国临床药理学杂志,1987,(3):235-240.
  • 6Rodriguez RF, Castillo JM, Del Pilar Castillo M, et al. Codeine/acetaminophen and hydrocodone/acetaminophen combination tablets for the management of chronic cancer pain in adults: a 23-day, prospective, double-blind, randomized, parallel-group study[J]. Clin Ther, 2007,29 (4) :581.
  • 7Chen ZR, Bochner F, Somogyi A. Simultaneous determination of codeine, norcodeine and morphine in biological fluids by high performance liquid chromatography with fluorescence detection[ J]. J Chromatogr, 1989,491 (2) :367.
  • 8Kartal M. LC method for the analysis of paracetamol, caffeine and codeine phosphate in pharmaceutical preparations[J]. J Pharm Biomed Anal, 2001, 26(5-6):857.
  • 9Satinsky D, Neto I, Solich P,et al. Sequential injection chranatographic determination of paracetamol, caffeine, and acetylsalicylic acid in pharmaceutical tablets[J]. J Sep Sci, 2004, 27(7- 8):529.
  • 10冯学标,李剑华,陈少荣.反相 HPLC 法测定氨酚待因片中扑热息痛及磷酸可待因的含量[J].广东药学院学报,1997,13(1):21-23. 被引量:3

引证文献3

二级引证文献10

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部